CAMBRIDGE, England--(BUSINESS WIRE)--Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies that help to improve patient outcomes with ...
Repligen said today it has acquired Atoll for up to $23.6 million, in a deal that will expand the buyer’s pre-packed column chromatography portfolio into high-throughput process development screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results